First isolations of Segniliparus rugosus from patients with cystic fibrosis
- PMID: 17670929
- PMCID: PMC2045363
- DOI: 10.1128/JCM.00765-07
First isolations of Segniliparus rugosus from patients with cystic fibrosis
Abstract
We report three cases of the new genus Segniliparus isolated from patients with cystic fibrosis. All isolates were unambiguously identified by 16S rRNA gene sequencing as Segniliparus rugosus (GenBank accession no. AY 60892). Drug susceptibility results that may enhance treatment for cystic fibrosis patients with this opportunistic pathogen are presented.
Figures
References
-
- Butler, W. R., M. M. Floyd, J. Brown, S. R. Toney, M. Daneshvar, R. C. Cooksey, J. Carr, A. Steigerwalt, and N. Charles. 2005. Novel mycolic acid-containing bacteria in the family Segniliparaceae fam. nov., including the genus Segniliparus gen. nov., with descriptions of Segniliparus rotundus sp. nov., and Segniliparus rugosus sp. nov. Int. J. Syst. Evol. Microbiol. 55:1615-1624. - PubMed
-
- CLSI. 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. CLSI document M100-S16 (ISBN 1-56238-588-7). CLSI, Wayne, PA.
-
- Griffith, D. E., T. Aksamit, B. A. Brown-Elliott, A. Catanzaro, C. Daley, F. Gordin, S. M. Holland, R. Horsburgh, G. Huitt, M. F. Iademarco, M. Iseman, K. Olivier, S. Ruoss, C. Fordham von Reyn, R. J. Wallace, Jr., and K. Winthrop on behalf of the ATS Mycobacterial Diseases Subcommittee. 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 175:367-416. - PubMed
-
- NCCLS. 2003. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard. NCCLS document M24-A (ISBN 1-56238-500-3). NCCLS, Wayne, PA. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases